These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8798046)

  • 1. A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.
    Sayegh N; Porée C; Baraton J; Skinningsrud K; Nantois C; Lallemand D
    Eur Radiol; 1996; 6(4):574-7. PubMed ID: 8798046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopentol (Imagopaque 300) compared with ioxaglate (Hexabrix 320) in knee arthrography. A clinical trial assessing immediate and late adverse events and diagnostic information.
    Railhac JJ; Brekke O
    Eur Radiol; 1997; 7 Suppl 4():S135-9. PubMed ID: 9204356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol.
    Wiklund LM; Brolin I; Sjöholm K
    Acta Radiol; 1994 Mar; 35(2):186-90. PubMed ID: 8172749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iopentol (Imagopaque 350) compared with iohexol (Omnipaque 350) in pediatric cardioangiography. A clinical trial assessing adverse events, ECG, blood pressure and diagnostic information.
    Kunnen M; De Greef D; Skinningsrud K
    Eur Radiol; 1997; 7 Suppl 4():S123-6. PubMed ID: 9204353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT. A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements).
    Valentine A; Jakobsen JA; Klaveness AJ
    Eur Radiol; 1997; 7 Suppl 4():S145-8. PubMed ID: 9204358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iopentol (Imagopaque 300 and 350) compared with iohexol (Omnipaque 300 and 350) in cerebral and aortic arch angiography. A clinical trial assessing adverse events and diagnostic information.
    Ericsson K; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S152-5. PubMed ID: 9204360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iopentol (Imagopaque 300) compared with iopromide (Ultravist 300) in pediatric angiocardiography. A clinical trial assessing adverse events, ECG and diagnostic information.
    Piéchaud JF; Iserin L; Aggoun Y; Kachaner J; Skinningsrud K
    Eur Radiol; 1997; 7 Suppl 4():S127-30. PubMed ID: 9204354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
    Palmers Y; De Greef D; Grynne BH; Smits J; Put E
    Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iopentol (Imagopaque 300) compared with iopromide (Ultravist 300) in abdominal CT. A multi-centre monitoring trial assessing adverse events and diagnostic information--results from 518 patients in Spain.
    Encina JL; Martí-Bonmatí L; Ronchera-Oms CL; Rodríguez V
    Eur Radiol; 1997; 7 Suppl 4():S115-9. PubMed ID: 9204351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study.
    Andersen PE; Bolstad B; Berg KJ; Justesen P; Thayssen P; Kloster YF
    Clin Radiol; 1993 Oct; 48(4):268-72. PubMed ID: 8243006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iopentol (Imagopaque 300) compared with iohexol (Omnipaque 300) and diatrizoate (Urografin 292) in pediatric urography. A clinical trial assessing adverse events and diagnostic information.
    Lanning P; Brekke O
    Eur Radiol; 1997; 7 Suppl 4():S120-2. PubMed ID: 9204352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
    Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of iopentol (Imagopaque 300 mg I/ml) compared with amidotrizoate (Peritrast 300 mg I/ml), both diluted to 2% (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CT. A clinical trial assessing patient tolerance, distribution of contrast medium and Hounsfield unit measurements.
    Friedrich JM; Skinningsrud K; Welter C; Eide H; Merkle E
    Eur Radiol; 1997; 7 Suppl 4():S140-4. PubMed ID: 9204357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous contrast medium application in elderly patients -- evaluation of Iopentol (Imagopaque 300)].
    Rathsmann P; Jacobs GF; Müller RD
    Rofo; 2004 Dec; 176(12):1826-31. PubMed ID: 15573295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate and delayed tolerance of iohexol and ioxaglate in lower limb phlebography: a double-blind comparative study in humans.
    Bertrand P; Delhommais A; Alison D; Rouleau P
    Acad Radiol; 1995 Aug; 2(8):683-6. PubMed ID: 9419625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iopentol (Imagopaque) in vascular procedures. A multi-centre monitoring trial assessing adverse events and diagnostic information--results from 3,587 patients in Germany.
    Muth CP; Henseke P; Grynne BH
    Eur Radiol; 1997; 7 Suppl 4():S104-8. PubMed ID: 9204349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial.
    Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T
    Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and electrocardiographic effects of iopentol in left ventricular angiography. Comparison of the low-osmolar, non-ionic iopentol (Imagopaque 350) and the hyper-osmolar, ionic metrizoate meglumine-Na-Ca (Isopaque Coronar 370) in patients with coronary heart disease.
    Vik-Mo H; Danielsen R; Skinningsrud K; Haider T; Bjørkhaug A
    Eur Radiol; 1997; 7 Suppl 4():S156-61. PubMed ID: 9204361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.